In vivo models of thrombosis for the antiphospholipid syndrome.

Abstract:

:Utilizing this unique animal model of thrombosis we demonstrated that human (IgG, IgM or IgA) polyclonal and monoclonal antiphospholipid antibodies derived from APS patients have a significant enhancing effect on thrombus formation. This effect is reversed by treatment of the mice with hydroxychloroquine (plaquenil). In addition murine polyclonal and monoclonal anticardiolipin antibodies induced by active immunization with human beta 2-GP1 or human anticardiolipin antibodies showed to have thrombogenic properties in CD1 mice. Antibodies with antihuman beta 2-GP1 activity alone did not seem to affect thrombus formation.

journal_name

Lupus

journal_title

Lupus

authors

Pierangeli SS,Harris EN

doi

10.1177/096120339600500524

subject

Has Abstract

pub_date

1996-10-01 00:00:00

pages

451-5

issue

5

eissn

0961-2033

issn

1477-0962

journal_volume

5

pub_type

杂志文章,评审

相关文献

LUPUS文献大全
  • Musculoskeletal involvement in systemic lupus erythematosus.

    abstract::Involvement of the musculoskeletal system is common if not universal in the clinical course of systemic lupus erythematosus (SLE). Joint involvement on the whole does not cause major erosive disease, however, recent developments in musculoskeletal imaging show clearly the presence of significant bony and soft tissue i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu2021oa

    authors: Zoma A

    更新日期:2004-01-01 00:00:00

  • The CD11b-integrin (ITGAM) and systemic lupus erythematosus.

    abstract::Variations at the ITGAM gene, which encodes for the CD11b chain of the Mac-1 (alphaMbeta2; CD11b/CD18; complement receptor-3) integrin, is one of the strongest genetic risk factors for systemic lupus erythematosus (SLE). More specifically, a genetic variant (rs1143679) which results in an arginine to histidine substit...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203313491851

    authors: Fagerholm SC,MacPherson M,James MJ,Sevier-Guy C,Lau CS

    更新日期:2013-06-01 00:00:00

  • Aberrant regulation of the integrin very late antigen-4 in systemic lupus erythematosus.

    abstract::Integrin very late antigen-4 (VLA4) is induced during inflammation and can regulate monocyte migration. It has been implicated in atherogenesis, a significant concern in systemic lupus erythematosus (SLE). The aim of this study was to define VLA4 expression in SLE monocytes. Flow cytometry, reverse transcription polym...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313475691

    authors: Rahimi H,Maurer K,Song L,Akhter E,Petri M,Sullivan KE

    更新日期:2013-03-01 00:00:00

  • Intestinal pseudo-obstruction syndrome in systemic lupus erythematosus.

    abstract::Intestinal pseudo-obstruction (IpsO) occurs in a small subgroup of patients with systemic lupus erythematosus (SLE), and has been under-recognized. The etiology and mechanisms are unclear. Herein, we report two cases. In case 1, IpsO occurred as the complication in a previously diagnosed SLE patient. In case 2, IpsO w...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203311405702

    authors: Zhang J,Fang M,Wang Y,Mao J,Sun X

    更新日期:2011-10-01 00:00:00

  • Changing hospitalization trends for systemic lupus erythematosus and rheumatoid arthritis in England.

    abstract:OBJECTIVES:Systemic lupus erythematosus (SLE) is a chronic, multisystemic, immune-mediated disorder associated with a substantial hospitalization risk. As a comparatively rare disease, there is a sparsity of research examining the burden of hospital admission in the contemporary era. We aim to describe national trends ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319853357

    authors: Hannah J,Galloway J,Kaul A

    更新日期:2019-06-01 00:00:00

  • Prothrombin as cofactor for antiphospholipids.

    abstract::Prothrombin is a common antigenic target of antiphospholipid antibodies, since anti-prothrombin antibodies are detected in about 50-90% of the patients. To allow proper immune recognition, prothrombin must be adsorbed on suitable anionic surfaces. The epitope(s) have not yet been identified: the majority of anti-proth...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339800700209

    authors: Galli M,Barbui T

    更新日期:1998-01-01 00:00:00

  • Interleukin-2 and systemic lupus erythematosus--fifteen years later.

    abstract::Systemic lupus erythematosus (SLE) is a highly heterogeneous disorder in which multiple immunologic abnormalities have been described. In this review, we thoroughly analyse the impaired T cell production of, and response to, interleukin-2 (IL-2) characteristic of patients with SLE. Since it was first reported, several...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120398678920028

    authors: Crispin JC,Alcocer-Varela J

    更新日期:1998-01-01 00:00:00

  • Urinary biomarkers for lupus nephritis: the role of the vascular cell adhesion molecule-1.

    abstract::Renal involvement is one of the main complications of systemic lupus erythematosus, causing a significant impact on patients' morbidity and mortality. Renal biopsy is still the gold standard of diagnosis, but it has many limitations. In this sense, several recent studies aim to identify biomarkers that not only predic...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203319826695

    authors: Gasparin AA,Pamplona Bueno de Andrade N,Hax V,Tres GL,Veronese FV,Monticielo OA

    更新日期:2019-03-01 00:00:00

  • Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.

    abstract::To determine whether killer cell immunologlobulin-like receptor (KIR) genotypes are associated with vasculitis, vascular arterial events or anticardiolipin (aCL) antibodies in patients with lupus. A total of 304 patients followed prospectively at the University of Toronto Lupus Clinic were assessed for the occurrence ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308089443

    authors: Toloza S,Pellett F,Chandran V,Ibanez D,Urowitz M,Gladman D

    更新日期:2008-09-01 00:00:00

  • Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus.

    abstract::We investigated the clinical significance of IgG phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in patients with SLE. The study population consisted of 140 patients with SLE. Sera were examined for IgG phospholipid-dependent anti-beta 2-GPI antibodies by ELISA. IgG phospholipid-dependent ant...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400609

    authors: Kaburaki J,Kuwana M,Yamamoto M,Kawai S,Matsuura E,Ikeda Y

    更新日期:1995-12-01 00:00:00

  • Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations.

    abstract::Antiphospholipid syndrome (APS) is a distinct autoimmune prothrombotic disorder due to pathogenic autoantibodies directed against proteins that bind to phospholipids. APS is characterized by arterial and venous thrombosis and their clinical sequelae. Catastrophic antiphospholipid syndrome (CAPS) is a rare and often fa...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313491024

    authors: Rangel ML,Alghamdi I,Contreras G,Harrington T,Thomas DB,Barisoni L,Andrews D,Wolf M,Asif A,Nayer A

    更新日期:2013-07-01 00:00:00

  • Unilateral facial erythematous patch as the presenting sign of systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that can have many cutaneous manifestations including malar rash, discoid rash or oral ulcer. Isolated unilateral involvement of face is uncommon in SLE. It lacks typical clinical features of LE, and may impose a diagnostic challenge for clinicians. H...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320957739

    authors: Ha DL,Lee GW,Shin K,Kim HS,Ko HC,Kim BS,Kim MB

    更新日期:2020-12-01 00:00:00

  • Mycobacteria and autoimmunity.

    abstract::Mycobacterial infections can cause a variety of different manifestations. The increasing incidence of these infections worldwide brought another medical dilemma: immunological manifestations characterized by the presence of many autoantibodies and concomitant presence of autoimmune diseases. The burden of tuberculosis...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203314559634

    authors: Machado Ribeiro F,Goldenberg T

    更新日期:2015-04-01 00:00:00

  • Infant perinatal thrombosis and antiphospholipid antibodies: a review.

    abstract::Perinatal thrombosis in infants born to mothers with antiphospholipid antibodies (aPL) is a rare event, but with risk of death or severe sequelae. We analysed 16 infants with such perinatal thrombosis reported in the literature in the last 20 years. Thromboses were arterial (13/16), mostly strokes (8/16). Hydrops feta...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203307079039

    authors: Boffa MC,Lachassinne E

    更新日期:2007-01-01 00:00:00

  • Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus Clinic.

    abstract:OBJECTIVE:Systemic lupus erythematosus (SLE), an autoimmune condition with diverse clinical manifestations, is reported to have different expression in populations of different ancestry. Most previous studies compared patients of different ethnic groups from geographically distinct cohorts. In our study, we aimed to ch...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313500547

    authors: Golder V,Connelly K,Staples M,Morand E,Hoi A

    更新日期:2013-11-01 00:00:00

  • Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.

    abstract::Objectives The aim of this study was to study the relationship between immunosuppressive drug treatment and survival in patients with systemic lupus erythematosus (SLE). Methods Patients who fulfilled four or more American College of Rheumatology criteria for SLE were followed longitudinally. Clinical characteristics,...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317739129

    authors: Mok CC,Tse SM,Chan KL,Ho LY

    更新日期:2018-04-01 00:00:00

  • Activation of the alternative complement pathway predicts renal outcome in patients with lupus nephritis.

    abstract:OBJECTIVES:The aims of this study were to clarify the activation of complement pathways in patients with lupus nephritis (LN), and to elucidate the association between these complement activation types and clinical outcomes. METHODS:We enrolled 115 patients with biopsy-proven LN from 2003 to 2016 from the lupus cohort...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320925165

    authors: Kim H,Kim T,Kim M,Lee HY,Kim Y,Kang MS,Kim J

    更新日期:2020-07-01 00:00:00

  • Renal transplantation for lupus nephritis: non-adherence and graft survival.

    abstract:OBJECTIVES:Poor adherence to immunosuppressive treatment is common in patients with systemic lupus erythematosus and may identify those with lupus nephritis (LN) who have a poorer prognosis. Non-adherence has also been reported to be a potential adverse outcome predictor in renal transplantation (rTp). We investigated ...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203319842641

    authors: Ntatsaki E,Vassiliou VS,Velo-Garcia A,Salama AD,Isenberg DA

    更新日期:2019-04-01 00:00:00

  • Systemic lupus erythematosus pregnancies: a case series from a tertiary, East Malaysian hospital.

    abstract::We performed a retrospective study of all systemic lupus erythematosus (SLE) pregnancies during a two-year period (2006-2007) to describe the clinical features, maternal and foetal outcomes in our centre. There were 17 pregnancies in 16 women with SLE. Our patients have a mean age of 28.31 years (SD 5.24) and a mean d...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308096661

    authors: Teh CL,Wong JS,Ngeh NK,Loh WL

    更新日期:2009-03-01 00:00:00

  • Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.

    abstract::Up to 80% of patients with systemic lupus erythematosus (SLE) are treated with nonsteroidal anti-inflammatory drugs (NSAID) for musculoskeletal symptoms, serositis and headache. This survey reviews the literature on non-selective and selective inhibitors of cyclooxygenases, with an emphasis on the efficacy and safety ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120300678828794

    authors: Ostensen M,Villiger PM

    更新日期:2000-01-01 00:00:00

  • Predictors of kidney disease in a cohort of pediatric patients with lupus.

    abstract:INTRODUCTION:Children with systemic lupus erythematosus (SLE) have an increased prevalence of kidney disease compared to their adult counterparts. Our goal was to identify potential clinical and laboratory predictors of renal disease. METHODS:We performed a cohort study of incident and prevalent patients with SLE aged...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315570162

    authors: Sule SD,Moodalbail DG,Burnham J,Fivush B,Furth SL

    更新日期:2015-07-01 00:00:00

  • Evaluation of early cardiac dysfunction in patients with systemic lupus erythematosus with or without anticardiolipin antibodies.

    abstract::The aim of this study was to use transthoracic Doppler echocardiographic (TTE) imaging methods to identify cardiac dysfunction, an indicator of subclinical atherosclerosis in asymptomatic systemic lupus erythematosus (SLE) patients in terms of cardiac effects. This study involved 80 patients: a study group (n = 50) an...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315570164

    authors: Barutcu A,Aksu F,Ozcelik F,Barutcu CA,Umit GE,Pamuk ON,Altun A

    更新日期:2015-09-01 00:00:00

  • Medical adherence in patients with systemic lupus erythematosus in Germany: predictors and reasons for non-adherence - a cross-sectional analysis of the LuLa-cohort.

    abstract::Objective Adherence to medication has a major impact on treatment control and success especially in chronic diseases but often remains unrecognized. Besides clinical, socioeconomic, disease-related and treatment-related parameters, general and personal health beliefs, as well as perception of health, can affect adhere...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318785245

    authors: Chehab G,Sauer GM,Richter JG,Brinks R,Willers R,Fischer-Betz R,Winkler-Rohlfing B,Schneider M

    更新日期:2018-09-01 00:00:00

  • Clinical profile of Chinese patients with systemic lupus erythematosus.

    abstract::In the 9-year period between 1982 and 1991, 137 patients attending a medical clinic of Queen Elizabeth Hospital, Hong Kong, were diagnosed as having systemic lupus erythematosus according to the American Rheumatism Association's criteria for classification. The female-to-male ratio was 16 to 1. Commonly the onset age ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200207

    authors: Lee SS,Li CS,Li PC

    更新日期:1993-04-01 00:00:00

  • Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand.

    abstract::Background The prevalence and variation by ethnicity of cutaneous lupus in New Zealand is not known. Therefore, a cross-sectional study to determine the prevalence and variation by ethnicity of cutaneous lupus in the ethnically diverse community of South Auckland, New Zealand, was undertaken. Methods Multiple sources ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316651745

    authors: Jarrett P,Thornley S,Scragg R

    更新日期:2016-11-01 00:00:00

  • High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage.

    abstract::The main objective of this study is to describe the presence of infections in patients with pulmonary haemorrhage and systemic lupus erythematosus. Patients with systemic lupus erythematosus and pulmonary haemorrhage were thoroughly evaluated in the first 48 hours with imaging plus bronchoscopy and bronchoalveolar flu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307086930

    authors: Rojas-Serrano J,Pedroza J,Regalado J,Robledo J,Reyes E,Sifuentes-Osornio J,Flores-Suárez LF

    更新日期:2008-04-01 00:00:00

  • Spot urine protein/creatinine ratio is unreliable estimate of 24 h proteinuria in lupus nephritis when the histological scores of activity index are higher.

    abstract:OBJECTIVES:The aim of this study was to evaluate the correlation and agreement of spot urine protein/creatinine (P/C) ratio with 24 h proteinuria in patients with lupus nephritis (LN) under different scores of activity index (AI). METHODS:In total, 90 pairs of 24 h urine and spot urine samples from 90 patients with bi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315570688

    authors: Zhang Q,Sun L,Jin L

    更新日期:2015-08-01 00:00:00

  • Reversible acute gastrointestinal syndrome associated with active systemic lupus erythematosus in patients admitted to hospital.

    abstract::Patients with systemic lupus erythematosus (SLE) frequently have gastrointestinal (GI) symptoms. These are usually self-limiting and related to treatment side-effects or concurrent illness. However, abdominal pain may be due to bowel ischaemia which can lead to infarction and perforation. The likelihood of these serio...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu433oa

    authors: Lian TY,Edwards CJ,Chan SP,Chng HH

    更新日期:2003-01-01 00:00:00

  • Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.

    abstract::Congenital heart block occurs in fetuses of Ro/SSA and La/SSB positive women. To investigate the stability of maternal autoantibody levels during pregnancy, we followed Ro52, Ro60 and La autoantibody IgG level variation and Ro52 subclass profiles longitudinally in selected congenital heart block risk pregnancies. Seru...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203306lu2309oa

    authors: Strandberg L,Salomonsson S,Bremme K,Sonesson S,Wahren-Herlenius M

    更新日期:2006-01-01 00:00:00

  • Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab.

    abstract:INTRODUCTION:Patients with systemic lupus erythematosus (SLE) with B-lymphocyte stimulator (BLyS) levels ≥ 2 ng/mL are at increased risk of flare. A regression analysis was undertaken to identify routine clinical measures that correlate with BLyS ≥ 2 ng/mL. Efficacy and safety of belimumab 10 mg/kg were examined in pat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315604909

    authors: Roth DA,Thompson A,Tang Y,Hammer AE,Molta CT,Gordon D

    更新日期:2016-04-01 00:00:00